AXL/MERTK inhibitor ONO-7475 potently synergizes with venetoclax and overcomes venetoclax resistance to kill FLT3-ITD acute myeloid leukemia.
Haematologica
; 107(6): 1311-1322, 2022 06 01.
Article
in En
| MEDLINE
| ID: mdl-34732043
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Leukemia, Myeloid, Acute
/
Drug Resistance, Neoplasm
/
Protein Kinase Inhibitors
/
C-Mer Tyrosine Kinase
Type of study:
Prognostic_studies
Limits:
Animals
/
Humans
Language:
En
Journal:
Haematologica
Year:
2022
Document type:
Article
Country of publication:
Italy